Genesis Drug Discovery & Development (GD3)

Genesis Drug Discovery & Development (GD³) is a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-IV clinical trials. The GD³ worldwide portfolio includes services for HTS and assay development, synthetic organic and medicinal chemistry, DMPK/in-vivo pharmacology and safety pharmacology, toxicology, and clinical trial services for the regulatory approval of novel drug and medical device products. Our highly-trained staff of expert chemists have managed diverse drug discovery programs from early lead identification to clinical development. We unite our significant experience in pharmaceutical and biotech companies and in academia, with state-of-the-art laboratories with the highest standard of instrumentation. We take great pride in our ability to provide custom solutions for the most complex chemistry challenges.